                               SEQUENCE LISTING

<110> GENERAL ELECTRIC COMPANY
 
<120> METHODS AND KITS FOR CELL ACTIVATION

<130> 312704-2

<140> 
<141> 

<160> 7     

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
tgactattaa gacttcctgt                                                   20


<210> 2
<211> 43
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<223> 5' phosphate

<400> 2
ttaatagtca ttccaaatat gagatgcgtt gttacaggaa gtc                         43


<210> 3
<211> 43
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<223> 5' phosphate

<400> 3
ttaatagtca ttccaacata tgagatggtt gttacaggaa gtc                         43


<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<223> 5' Maleimide functional group and C6 spacer

<400> 4
acaggaagtc ttaatagtca                                                   20


<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
atcaatgatg cataacatct                                                   20


<210> 6
<211> 43
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<223> 5' phosphate 

<400> 6
catcattgat ttagacactg aaaaagttcg aggagatgtt atg                         43


<210> 7
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<223> 5' Maleimide functional group and C6 spacer

<400> 7
catcattgat ttagacactg aaaaa                                             25


